News

Merck KGaA to Acquire Bio-Techne for $11.3 Billion to Bolster Life Science Division

Yuvraj — Fri, 26 Jun 2026 07:32:09 +0000

The German pharmaceutical group Merck KGaA announced that it has entered into a definitive agreement to purchase the United States-based biotechnology firm Bio-Techne for $11.3 billion. This transaction represents the largest deal for the Darmstadt-based organization in more than a decade, as it seeks to significantly enhance its global life sciences business. Under the terms […]

The post Merck KGaA to Acquire Bio-Techne for $11.3 Billion to Bolster Life Science Division first appeared on World Pharma Today.

Novartis and Antares Therapeutics Form Strategic Partnership for Cancer Drug Development

Yuvraj — Fri, 26 Jun 2026 07:23:30 +0000

Novartis has finalized a significant collaboration agreement with Antares Therapeutics to advance the discovery and development of small molecule therapies for various cancers. The deal, which could reach a total value of $1.9 billion, focuses on addressing oncology targets that have historically been categorized as undruggable. Under the terms of the agreement, Novartis will provide […]

The post Novartis and Antares Therapeutics Form Strategic Partnership for Cancer Drug Development first appeared on World Pharma Today.

Abu Dhabi and MSD Partner to Enhance Healthcare Access via New Logistics Hub

Yuvraj — Fri, 26 Jun 2026 05:12:11 +0000

The Department of Health – Abu Dhabi (DoH) has announced a strategic collaboration with MSD to evaluate the feasibility of establishing an Abu Dhabi logistics hub. Located within the Health, Endurance, Longevity, and Medicine (HELM) Cluster, this planned facility is designed to streamline the distribution of a comprehensive portfolio of pharmaceutical products across diverse regional […]

The post Abu Dhabi and MSD Partner to Enhance Healthcare Access via New Logistics Hub first appeared on World Pharma Today.

4 Health Supplement Brands Using Science-Backed Ingredients

Yuvraj — Thu, 25 Jun 2026 13:45:08 +0000

Most supplement shoppers don’t realize how wide the gap is between brands that actually back their formulas with research and brands that just use convincing packaging. Health supplement brands operating in today’s market face real pressure: FDA DSHEA guidelines are strict, health claims can get a company into serious legal trouble, and consumers are more […]

The post 4 Health Supplement Brands Using Science-Backed Ingredients first appeared on World Pharma Today.

Best AI Healthcare Software Development Companies in 2026

Yuvraj — Thu, 25 Jun 2026 09:51:01 +0000

Not every company that builds software for healthcare builds AI for healthcare. The distinction matters. Rule-based alert systems, workflow portals, and EHR modules are healthcare software. Predictive models, NLP-driven documentation, and computer vision for clinical imaging are healthcare AI. The companies on this list build the second category. This guide uses a different structure than […]

The post Best AI Healthcare Software Development Companies in 2026 first appeared on World Pharma Today.

Bayer and Iambic Collaboration Expands AI Drug Discovery Efforts

Yuvraj — Thu, 25 Jun 2026 05:47:49 +0000

Bayer has strengthened its pharmaceutical and ophthalmology portfolio through two separate transactions, completing the acquisition of Perfuse Therapeutics while also entering a collaboration agreement with Iambic Therapeutics. The moves provide Bayer with full ownership of Perfuse’s lead asset, PER-001, and expand its access to advanced artificial intelligence technologies aimed at accelerating drug development. The acquisition […]

The post Bayer and Iambic Collaboration Expands AI Drug Discovery Efforts first appeared on World Pharma Today.

US Clinical Trials Plan Aims to Restore Research Leadership

Yuvraj — Wed, 24 Jun 2026 13:15:03 +0000

The US Department of Health and Human Services (HHS) has outlined a new strategy aimed at reinforcing the country’s position in pharmaceutical research as competition from China intensifies. Through an initiative called Operation Trailblazer, HHS plans to introduce measures designed to accelerate drug development, reduce delays in clinical studies, expand participation in research programmes, and […]

The post US Clinical Trials Plan Aims to Restore Research Leadership first appeared on World Pharma Today.

Lilly and BioArctic Partner on BrainTransporter Technology

Yuvraj — Wed, 24 Jun 2026 13:06:58 +0000

Eli Lilly and Company has entered into a research and collaboration agreement with Swedish biopharmaceutical company BioArctic to advance a potential treatment for neurodegenerative diseases. Under the arrangement, the companies will combine BioArctic’s BrainTransporter Technology with an undisclosed Lilly drug candidate. BioArctic will receive an upfront payment of $30m and may earn up to $770m […]

The post Lilly and BioArctic Partner on BrainTransporter Technology first appeared on World Pharma Today.

AbbVie Acquires Apogee in $10.9 Billion Healthcare Deal

Yuvraj — Wed, 24 Jun 2026 12:58:04 +0000

In a significant expansion of its research and development capabilities, a definitive agreement has been reached where AbbVie acquires Apogee Therapeutics for $10.9 billion. This strategic transaction is centered around the addition of zumilokibart, a highly anticipated IL-13 antibody, to the acquiring company’s expanding pipeline. By bringing this advanced asset in-house, the organization aims to […]

The post AbbVie Acquires Apogee in $10.9 Billion Healthcare Deal first appeared on World Pharma Today.

The Growing Challenge of Patient Non-Compliance in Modern Healthcare

Yuvraj — Wed, 24 Jun 2026 10:20:24 +0000

Advances in medical research, pharmaceutical innovation, and healthcare technology have significantly improved the ability of healthcare providers to diagnose, treat, and manage a wide range of conditions. Despite these advancements, one persistent challenge continues to impact patient outcomes across virtually every area of healthcare: patient non-compliance. Whether it involves failing to take prescribed medications, missing […]

The post The Growing Challenge of Patient Non-Compliance in Modern Healthcare first appeared on World Pharma Today.